[1]
M. de A. Carvalho Sousa, G. C. Matos de Oliveira, e L. J. de Oliveira Andrade, “Surfactant in SARS-CoV-2 - a therapeutic option based on underlying lung cell damage?”, cmbio, vol. 19, nº 4, p. 602–605, dez. 2020.